Search clinical trials for: AMG 224
Total 4478 results
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
AmgenSuspendedA Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLCSmall Cell Lung CancerUnited States
-
AmgenCompletedRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Clear Cell Renal Carcinoma | Renal Cell AdenocarcinomaFrance, United States, Germany
-
AmgenCompleted
-
CytokineticsCompletedHeart Failure With Reduced Ejection FractionUnited States, Hungary, France, Canada, Netherlands, Germany, Poland, Italy, Sweden
-
Johann Wolfgang Goethe University HospitalPitzer StiftungUnknownNeurologic ManifestationsGermany
-
Gannex Pharma Co., Ltd.RecruitingNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisChina
-
Revolution Medicines, Inc.Sanofi; AmgenActive, not recruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Taiwan, Spain, United Kingdom, Italy, Australia, France, Germany
-
CytokineticsCompletedHeart FailureUnited States, Canada, Germany, Italy, Netherlands, Belgium, France, Czechia, Australia, Russian Federation, Hungary, Poland, Bulgaria, Slovakia, United Kingdom, Finland, Greece, Lithuania, Norway
-
Roswell Park Cancer InstituteAmgenCompletedOsteoporosis | Osteopenia | Allogeneic Hematopoietic Stem Cell Transplantation RecipientUnited States
-
Curon Biopharmaceutical (Australia) Co Pty LtdNovotech (Australia) Pty LimitedTerminatedRelapsed Lymphoid Malignancies | Refractory Lymphoid MalignanciesAustralia
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedCat Allergy | Cat HypersensitivityUnited States
-
NovartisCompletedSore Throat Due to a Common ColdGermany
-
City of Hope Medical CenterAddario Lung Cancer Medical InstituteWithdrawnExtensive Stage Small Cell Lung CarcinomaUnited States
-
Martin Andreas, M.D.National Bank of Austria; Orphan MedicalCompleted
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
NantCell, Inc.CompletedSarcoma | Ewing's Sarcoma | Primitive Neuroectodermal Tumors (PNETs) | Askin's Tumors | Desmoplastic Small Round Cell Tumors | Estraosseous Ewing's Tumor | Ewing's Family Tumor
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedNon-alcoholic Fatty Liver DiseaseUnited States
-
AmgenTerminatedActive Systemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, Canada, Spain, Italy, Mexico, Japan, Turkey, Austria, Greece, Colombia, Switzerland, Poland, France, Bulgaria, Hong Kong, Russian Federation, Chile
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Thrombocytopenia | Refractory Multiple MyelomaUnited States
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Not yet recruiting
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
Aviragen TherapeuticsCompleted
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
AmgenNot yet recruiting
-
Daewoong Pharmaceutical Co. LTD.CompletedT2DM (Type 2 Diabetes Mellitus)Korea, Republic of
-
AmgenTerminatedAdvanced Solid TumorsUnited States
-
AmgenRecruitingAtopic DermatitisKorea, Republic of, Australia, United States, United Kingdom, Hong Kong, Turkey, Brazil, Argentina, Canada
-
AmgenActive, not recruiting
-
AmgenCompletedFracture HealingFinland, Italy, Sweden, United States, Belgium, Switzerland, Canada, Hong Kong, Hungary, Germany, Netherlands, Bulgaria, Australia, Poland, Greece, Denmark, United Kingdom, Estonia, India, New Zealand, Latvia, Lithuania, Argentina, Sl...
-
Inovio PharmaceuticalsCompletedProstate CancerUnited States
-
NantCell, Inc.CompletedPancreatic Cancer | Adenocarcinoma of the Pancreas | Metastatic Pancreatic CancerUnited States
-
AmgenCompleted
-
GlaxoSmithKlineCompletedAlzheimer's DiseaseUnited States, Australia, Spain, Bulgaria, Poland, Germany, Philippines, Singapore, Belgium, Canada, Hong Kong, Korea, Republic of, Finland, Slovenia, Czechia, France, South Africa, Sweden, Netherlands, Malaysia, United Kingdom, S...
-
AmgenCompletedCarcinoma | Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumors | Oncology | Tumors | Metastases | Gynecological MalignanciesBelgium, United States, Australia
-
Alexza Pharmaceuticals, Inc.CelerionCompleted
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
AmgenCompletedMyelodysplastic Syndromes | Thrombocytopenia
-
AmgenNot yet recruiting
-
AmgenRecruitingAtopic DermatitisUnited States, Korea, Republic of, Taiwan, Spain, Croatia, China, Greece, Belgium, Thailand, Puerto Rico, Hungary, Poland, Germany, Brazil, Italy, Japan, Canada, France, Romania, Chile
-
AmgenCompletedSecondary HyperparathyroidismChina
-
Bausch Health Americas, Inc.TerminatedPsoriasisUnited States, Australia, France, Canada, Denmark
-
Translational Research in OncologyCompletedStudy of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian CancerOvarian NeoplasmsUnited States, France, Ireland, Germany, Israel, Canada, Spain